US 10617707
Oligonucleotides to treat eye disease
granted A61KA61K31/7125A61K9/0048
Quick answer
US patent 10617707 (Oligonucleotides to treat eye disease) held by ProQR Therapeutics II B.V. expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ProQR Therapeutics II B.V.
- Grant date
- Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/7125, A61K9/0048, A61P, A61P27/02